{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:30:20Z","timestamp":1791307820073,"version":"4.3.1"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1213\/ane.0b013e3181cbd815","type":"journal-article","created":{"date-parts":[[2010,3,18]],"date-time":"2010-03-18T05:34:32Z","timestamp":1268890472000},"page":"185-190","source":"Crossref","is-referenced-by-count":36,"title":["Functional Properties of RYR1 Mutations Identified in Swedish Patients with Malignant Hyperthermia and Central Core Disease"],"prefix":"10.1213","volume":"111","author":[{"given":"Mirko","family":"Vukcevic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Broman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunilla","family":"Islander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Bodelsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Ranklev-Twetman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens R.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Treves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-32-20210902","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/bja\/85.1.118","article-title":"Malignant hyperthermia. Advances in clinical management and diagnosis.","volume":"85","author":"Hopkins","year":"2000","journal-title":"Br J Anaesth"},{"key":"R3-32-20210902","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1136\/adc.88.12.1051","article-title":"Central core disease: clinical, pathological, and genetic features.","volume":"88","author":"Quinlivan","year":"2003","journal-title":"Arch Dis Child"},{"key":"R4-32-20210902","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.coph.2008.01.005","article-title":"Congenital muscle disorders with cores: the ryanodine receptor calcium channel paradigm.","volume":"8","author":"Treves","year":"2008","journal-title":"Curr Opin Pharmacol"},{"key":"R5-32-20210902","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/humu.20356","article-title":"Mutations in RYR1 in malignant hyperthermia and central core disease.","volume":"27","author":"Robinson","year":"2006","journal-title":"Hum Mutat"},{"key":"R6-32-20210902","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.nmd.2005.06.008","article-title":"Ryanodine receptor 1 mutations, dysregulation of calcium homeostasis and neuromuscular disorders.","volume":"15","author":"Treves","year":"2005","journal-title":"Neuromuscul Disord"},{"key":"R7-32-20210902","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.bi.56.070187.002143","article-title":"Intracellular calcium homeostasis.","volume":"56","author":"Carafoli","year":"1987","journal-title":"Ann Rev Biochem"},{"key":"R8-32-20210902","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/35036035","article-title":"The versatility and universality of calcium signaling.","volume":"1","author":"Berridge","year":"2000","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R9-32-20210902","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/nrm1155","article-title":"Calcium signaling: dynamics, homeostasis and remodeling.","volume":"4","author":"Berridge","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R10-32-20210902","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/mus.20512","article-title":"Sarcoplasmic reticulum: the dynamic calcium governor of muscle.","volume":"33","author":"Rossi","year":"2006","journal-title":"Muscle Nerve"},{"key":"R11-32-20210902","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10974-005-9001-1","article-title":"Novel sarcoendoplasmic reticulum proteins and calcium homeostasis in striated muscles.","volume":"26","author":"Divet","year":"2005","journal-title":"J Muscle Res Cell Motil"},{"key":"R12-32-20210902","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1083\/jcb.140.4.831","article-title":"Role of ryanodine receptors in the assembly of calcium release units in skeletal muscle.","volume":"140","author":"Protasi","year":"1998","journal-title":"J Cell Biol"},{"key":"R13-32-20210902","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/humu.20231","article-title":"Correlations between genotype and pharmacological, histological, functional and clinical phenotypes in malignant hyperthermia susceptibility.","volume":"26","author":"Monnier","year":"2005","journal-title":"Hum Mutat"},{"key":"R14-32-20210902","doi-asserted-by":"crossref","first-page":"5995","DOI":"10.1074\/jbc.274.9.5995","article-title":"Skeletal muscle type ryanodine receptor is involved in calcium signaling in human B lymphocytes.","volume":"274","author":"Sei","year":"1999","journal-title":"J Biol Chem"},{"key":"R15-32-20210902","doi-asserted-by":"crossref","first-page":"48077","DOI":"10.1074\/jbc.M107134200","article-title":"B-lymphocytes from malignant hyperthermia-susceptible patients have an increased sensitivity to skeletal muscle ryanodine receptor activators.","volume":"276","author":"Girard","year":"2001","journal-title":"J Biol Chem"},{"key":"R16-32-20210902","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/bja\/aep061","article-title":"Mutation screening of the RYR1-cDNA from peripheral B lymphocytes in 15 Swedish malignant hyperthermia index cases.","volume":"102","author":"Broman","year":"2009","journal-title":"Br J Anaesth"},{"key":"R17-32-20210902","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/00000542-199404000-00008","article-title":"A clinical grading scale to predict malignant hyperthermia susceptibility.","volume":"80","author":"Larach","year":"1994","journal-title":"Anesthesiology"},{"key":"R18-32-20210902","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/hmg\/10.25.2879","article-title":"Identification of four novel mutations in the C-terminal membrane spanning domain of the ryanodine receptor 1: association with central core disease and alteration of calcium homeostasis.","volume":"10","author":"Tilgen","year":"2001","journal-title":"Hum Mol Genet"},{"key":"R19-32-20210902","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1097\/00000542-200606000-00014","article-title":"Characterization of ryanodine receptor-mediated calcium release in human B cells: relevance to diagnostic testing for malignant hyperthermia.","volume":"104","author":"McKinney","year":"2006","journal-title":"Anesthesiology"},{"key":"R20-32-20210902","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1097\/00000542-200006000-00040","article-title":"Hypersensitivity of malignant hyperthermia susceptible swine skeletal muscle to caffeine is mediated by high resting myoplasmic Ca2.","volume":"92","author":"Lopez","year":"2000","journal-title":"Anesthesiology"},{"key":"R21-32-20210902","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1152\/ajpcell.00297.2004","article-title":"Enhanced response to caffeine and 4-chloro-m-cresol in malignant hyperthermia susceptible muscle is related in part to chronically elevated resting Ca2.","volume":"288","author":"Lopez","year":"2005","journal-title":"Am J Physiol Cell Physiol"},{"key":"R22-32-20210902","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1093\/brain\/awl077","article-title":"Central core disease is due to RYR1 mutations in more than 90 of patients.","volume":"129","author":"Wu","year":"2006","journal-title":"Brain"},{"key":"R24-32-20210902","doi-asserted-by":"crossref","first-page":"43838","DOI":"10.1074\/jbc.M403612200","article-title":"Effect of ryanodine receptor mutations on IL-6 release and intracellular calcium homeostasis in human myotubes from malignant hyperthermia susceptible individuals and patients affected by central core disease.","volume":"279","author":"Ducreaux","year":"2004","journal-title":"J Biol Chem"},{"key":"R25-32-20210902","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1042\/BJ20051282","article-title":"Functional properties of ryanodine receptors carrying 3 amino acid substitutions identified in patients affected by multi-minicore disease and central core disease, expressed in immortalised lymphocytes.","volume":"395","author":"Ducreux","year":"2006","journal-title":"Biochem J"},{"key":"R26-32-20210902","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/01.anes.0000299431.81267.3e","article-title":"Identification and biochemical characterization of a novel ryanodine receptor gene mutation associated with malignant hyperthermia.","volume":"108","author":"Anderson","year":"2008","journal-title":"Anesthesiology"},{"key":"R27-32-20210902","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/humu.20409","article-title":"Two central core disease CCD deletions in the C-terminal region of RYR1 alter muscle EC coupling by distinct mechanisms.","volume":"28","author":"Lyfenko","year":"2007","journal-title":"Hum Mutat"},{"key":"R28-32-20210902","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/humu.20878","article-title":"Increasing the number of diagnostic mutations in malignant hyperthermia.","volume":"30","author":"Levano","year":"2009","journal-title":"Hum Mutat"},{"key":"R29-32-20210902","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1152\/ajpcell.00173.2004","article-title":"Functional analysis of the R1068H malignant hyperthermia mutation in the DHPR reveals an unexpected influence of the III-IV loop on skeletal muscle EC coupling.","volume":"287","author":"Weiss","year":"2004","journal-title":"Am J Physiol Cell Physiol"},{"key":"R30-32-20210902","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/bja\/86.2.283","article-title":"Guidelines for molecular genetic detection of susceptibility to malignant hyperthermia.","volume":"86","author":"Urwyler","year":"2001","journal-title":"Br J Anaesth"}],"container-title":["Anesthesia & Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000539-201007000-00032","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:27:14Z","timestamp":1786112834000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-201007000-00032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0b013e3181cbd815","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}